Acute-phase proteins in relation to neuropsychiatric symptoms and use of psychotropic medication in Huntington's disease

作者：Bouwens J A^*; Hubers A A M; van Duijn E; Cobbaert C M; Roos R A C; van der Mast R C; Giltay E J

来源：European Neuropsychopharmacology, 2014, 24(8): 1248-1256.

DOI：10.1016/j.euroneuro.2014.05.004

• Acute-phase proteins
• Neuropsychiatric symptoms
• Psychotropics
• Antipsychotics
• Huntington's disease

Activation of the innate immune system has been postulated in the pathogenesis of Huntington's disease (HD). We studied serum concentrations of C-reactive protein (CRP) and low albumin as positive and negative acute-phase proteins in HD. Multivariate linear and logistic regression was used to study the association between acute-phase protein levels in relation to clinical, neuropsychiatric, cognitive, and psychotropic use characteristics in a cohort consisting of 122 HD mutation carriers and 42 controls at first biomarker measurement, and 85 HD mutation carriers and 32 controls at second biomarker measurement. Significant associations were found between acute-phase protein levels and Total Functioning Capacity (TFC) score, severity of apathy, cognitive impairment, and the use of antipsychotics. Interestingly, all significant results with neuropsychiatric symptoms disappeared after additional adjusting for antipsychotic use. High sensitivity CRP levels were highest and albumin levels were lowest in mutation carriers who continuously used antipsychotics during follow-up versus those that had never used antipsychotics (mean difference for CRP 1.4 SE mg/L; P=0.04; mean difference for albumin 3 SE g/L; P<0.001). The associations found between acute-phase proteins and TFC score, apathy, and cognitive impairment could mainly be attributed to the use of antipsychotics. This study provides evidence that HD mutation carriers who use antipsychotics are prone to develop an acute-phase response.

• 出版日期2014-8